97140 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
Sub-classes:FLAGELLIN EPITOPE PEPTIDES AND USES THEREOF
#2ANTIBODY BASED TREATMENT TO REDUCE GUT BACTERIAL GLYCAN AND ASSOCIATED BACTERIA
#3AFFINITY PURIFICATION, PROXIMITY-BASED SORTASE LIGATION, AND DETECTION OF PROTEINS WITH PRECURSOR PEPTIDES AND B1 PROTEINS FROM LASSO PEPTIDE BIOSYNTHESIS SYSTEMS
#4ANTI-ROXP ANTIBODIES AND USES THEREOF
#5ANTIBODY FOR HAIR IMPROVEMENT USE
#6RED LIGHT-CONTROLLED PROTEIN DIMERIZATION SYSTEMS
#7ANTIBODY FOR HAIR IMPROVEMENT USE
#8Antibody specific to alpha-toxin of and uses thereof
#9Complete genome sequence of the methanogen
#10Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGM
#11A SPECIFIC, RAPID TEST DIFFERENTIATING GRAM POSITIVE AND GRAM NEGATIVE BACTERIA
#12Basehit, a high-throughput assay to identify proteins involved in host-microbe interaction
#13METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION
#14TREATMENT OF HIDRADENITIS SUPPURATIVA
#15Complete genome sequence of the methanogen
#16Compositions containing anti-HIV ostrich antibodies
#17Process for the preparation of an antibody-rifamycin conjugate
#18Human antibody specifically binding to acne bacteria using phage display technique, and use thereof
#19Method of treating an eye disorder by inhibiting or disrupting bacterial biofilm formation
#20Antibody and antibody-containing composition
#21Combined enteropathogen recombinant construct
#22IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
#23Methods for isolating a target analyte from a heterogenous sample
#24Isolating a target analyte from a body fluid
#25Analyzing bacteria without culturing
#26Antibody and antibody-containing composition
#27Compositions and methods for the treatment and prevention of Ebp pilus-related diseases
#28Combined enteropathogen recombinant construct
#29Process for the preparation of an antibody-rifamycin conjugate
#30Complete genome sequence of the methanogen
#31Polypeptides derived from and their use for vaccination and the generation of therapeutic antibodies
#32Antibody preparations
#33Methods for isolating a target analyte from a heterogenous sample
#34Antibody and antibody-containing composition
#35Separating target analytes using alternating magnetic fields
#36Opsonic and protective monoclonal antibodies against gram-positive pathogens
#37Detection of polymyxins
#38Compositions and methods for the treatment and prevention of Ebp pilus-related diseases
#39Methods for isolating a target analyte from a heterogeneous sample
#40Antibody for epitope tagging, hybridoma cell line and uses thereof
#41Cell wall polymers of and uses thereof
#42Antibody preparations
#43Treatment and prevention of infections
#44Rhamno-polysaccharide from clonal complex 17 and uses thereof
#45Human binding molecules having killing activity against enterococci
#46Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections
#47Methods for isolating a target analyte from a heterogeneous sample
#48ENTEROCOCCUS ANTIGENS
#49PEPTIDES PROTECTIVE AGAINST E. FAECALIS, METHODS AND USES RELATING THERETO
#50Complete genome sequence of the methanogen
#51INACTIVATED STAPHYLOCOCCAL WHOLE-CELL VACCINE
#52Process for preparing an immunoglobulin composition
#53Antibody preparations
#54Human binding molecules against and
#55Immune system modulating composition
#56antigens
#57PURIFICATION OF BACTERIAL ANTIGENS
#58Human binding molecules having killing activity against enterococci and uses thereof
#59Compositions for isolating a target analyte from a heterogeneous sample
#60ISOLATING A TARGET ANALYTE FROM A BODY FLUID
#61COMPOSITIONS AND METHOD FOR ISOLATING MID-LOG PHASE BACTERIA
#62COMPOSITIONS
#63Analyzing bacteria without culturing
#64Extracting low concentrations of bacteria from a sample
#65Methods for isolating a target analyte from a heterogeneous sample
#66Separating target analytes using alternating magnetic fields
#67Enterococcus antigens
#68Immunogenic compositions for gram positive bacteria such as
#69Treatment and prevention of infections
#70OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA
#71Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#72Inactivated staphylococcal whole-cell vaccine
#73PURIFICATION OF BACTERIAL ANTIGENS
#74Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
#75Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
#76Human binding molecules having killing activity against enterococci and uses thereof
#77Immunogen adherence inhibitor directed to organisms and method of making and using it
#78Immunogen adherence inhibitor directed to lactobacillus organisms and method of making and using it
#79Enterococcus Antigens
#80TREATMENT OF MICRO-ORGANISM INFECTION
#81Purification of bacterial antigens
#82Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#83Treatment of micro-organism infection
#84Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
#85Monoclonal antibodies specific for cariogenic bacteria
#86Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria
#87Treatment of micro-organism infection
#88Polypeptides implicated in the expression of resistance to glycopeptides, in particular in Gram-positive bacteria, nucleotide sequence coding for these polypeptides and use for diagnosis
#89Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them